-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=1&pageId=114991113&revisedVersion=6
September 19, 2021 - Practice Center EU—European Union F FAIR—findable, accessible, interoperable, reusable FDA—Food and Drug
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?pageId=114991113&selectedPageVersions=5&selectedPageVersions=6
September 20, 2021 - Practice Center EU—European Union F FAIR—findable, accessible, interoperable, reusable FDA—Food and Drug
-
cmext.ahrq.gov/confluence/display/PUB/Acronyms+and+Glossary
September 20, 2021 - Practice Center EU—European Union F FAIR—findable, accessible, interoperable, reusable FDA—Food and Drug
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991692
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991535
October 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991567
September 26, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991706
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991703
September 09, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991690
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991533
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991695
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991693
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991706
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991695
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991533
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991535
October 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991690
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991692
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991567
September 26, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991693
September 10, 2021 - guidelines cover virtually all aspects of the diagnosis, evaluation, monitoring, secondary causes as well as drug … and non-drug treatment of hypertension.